William J. Israelsen

5.1k total citations · 1 hit paper
17 papers, 2.0k citations indexed

About

William J. Israelsen is a scholar working on Cancer Research, Molecular Biology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, William J. Israelsen has authored 17 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cancer Research, 8 papers in Molecular Biology and 3 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in William J. Israelsen's work include Cancer, Hypoxia, and Metabolism (12 papers), Metabolism, Diabetes, and Cancer (7 papers) and Mitochondrial Function and Pathology (3 papers). William J. Israelsen is often cited by papers focused on Cancer, Hypoxia, and Metabolism (12 papers), Metabolism, Diabetes, and Cancer (7 papers) and Mitochondrial Function and Pathology (3 papers). William J. Israelsen collaborates with scholars based in United States, Canada and Ireland. William J. Israelsen's co-authors include Matthew G. Vander Heiden, Clary B. Clish, Craig J. Thomas, Jian‐kang Jiang, Laura E. Gleeson, Daniel Johnston, Raquel Domingo-Fernandéz, Eva M. Pålsson‐McDermott, Luke O'neill and Susan R. Quinn and has published in prestigious journals such as Cell, Genes & Development and SHILAP Revista de lepidopterología.

In The Last Decade

William J. Israelsen

16 papers receiving 2.0k citations

Hit Papers

Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β In... 2015 2026 2018 2022 2015 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
William J. Israelsen United States 12 1.2k 811 642 238 157 17 2.0k
Jonathan L. Coloff United States 24 1.5k 1.3× 746 0.9× 391 0.6× 386 1.6× 459 2.9× 33 2.4k
Niall S. Kenneth United Kingdom 21 1.2k 1.0× 785 1.0× 312 0.5× 219 0.9× 242 1.5× 28 1.9k
Beatrice Hoyos United States 19 1.5k 1.2× 730 0.9× 878 1.4× 177 0.7× 250 1.6× 26 2.8k
Xiaoling Liu China 24 788 0.7× 329 0.4× 439 0.7× 292 1.2× 126 0.8× 95 1.6k
Can G. Pham United States 16 1.4k 1.2× 710 0.9× 438 0.7× 165 0.7× 369 2.4× 19 2.4k
Pelagia Foka Greece 17 949 0.8× 252 0.3× 340 0.5× 316 1.3× 249 1.6× 35 1.9k
Sun‐Il Hwang United States 22 1.8k 1.5× 304 0.4× 416 0.6× 161 0.7× 354 2.3× 44 2.7k
Atan Gross Israel 19 2.0k 1.6× 324 0.4× 302 0.5× 326 1.4× 288 1.8× 31 2.5k
Takla Griss Canada 9 1.8k 1.5× 890 1.1× 829 1.3× 369 1.6× 349 2.2× 9 2.8k
Lynn S. Taylor United States 15 613 0.5× 423 0.5× 828 1.3× 170 0.7× 224 1.4× 19 1.8k

Countries citing papers authored by William J. Israelsen

Since Specialization
Citations

This map shows the geographic impact of William J. Israelsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William J. Israelsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William J. Israelsen more than expected).

Fields of papers citing papers by William J. Israelsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William J. Israelsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William J. Israelsen. The network helps show where William J. Israelsen may publish in the future.

Co-authorship network of co-authors of William J. Israelsen

This figure shows the co-authorship network connecting the top 25 collaborators of William J. Israelsen. A scholar is included among the top collaborators of William J. Israelsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William J. Israelsen. William J. Israelsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Madelaire, Carla Bonetti, et al.. (2022). Fibroblasts as an experimental model system for the study of comparative physiology. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology. 260. 110735–110735. 16 indexed citations
2.
Israelsen, William J., et al.. (2021). Breeding and hibernation of captive meadow jumping mice (Zapus hudsonius). PLoS ONE. 16(5). e0240706–e0240706. 4 indexed citations
3.
Israelsen, William J., et al.. (2021). Courtship Behavior of the Meadow Jumping Mouse (Zapus hudsonius). Western North American Naturalist. 81(2). 267–272.
4.
Israelsen, William J., et al.. (2019). Nesting box imager: Contact-free, real-time measurement of activity, surface body temperature, and respiratory rate applied to hibernating mouse models. PLoS Biology. 17(7). e3000406–e3000406. 13 indexed citations
5.
Hosios, Aaron M., et al.. (2019). Cancer‐associated mutations in human pyruvate kinase M2 impair enzyme activity. FEBS Letters. 594(4). 646–664. 17 indexed citations
6.
Caron, Tyler, Stephen C. Artim, William J. Israelsen, et al.. (2018). Cutaneous Dermatophilosis in a Meadow Jumping Mouse (Zapus hudsonius).. PubMed. 68(1). 25–30. 3 indexed citations
7.
Lau, Allison N., William J. Israelsen, Jatin Roper, et al.. (2017). PKM2 is not required for colon cancer initiated by APC loss. SHILAP Revista de lepidopterología. 5(1). 10–10. 37 indexed citations
8.
Dayton, Talya L., Vasilena Gocheva, Kathryn Miller, et al.. (2016). Germline loss of PKM2 promotes metabolic distress and hepatocellular carcinoma. Genes & Development. 30(9). 1020–1033. 120 indexed citations
9.
Dayton, Talya L., Vasilena Gocheva, Kathryn Miller, et al.. (2016). Abstract PR04: Germline loss of PK-M2 promotes metabolic syndrome and hepatocellular carcinoma. Molecular Cancer Research. 14(4_Supplement). PR04–PR04. 3 indexed citations
10.
Israelsen, William J. & Matthew G. Vander Heiden. (2015). Pyruvate kinase: Function, regulation and role in cancer. DSpace@MIT (Massachusetts Institute of Technology). 18 indexed citations
11.
Israelsen, William J. & Matthew G. Vander Heiden. (2015). Pyruvate kinase: Function, regulation and role in cancer. Seminars in Cell and Developmental Biology. 43. 43–51. 420 indexed citations
12.
Pålsson‐McDermott, Eva M., Annie M. Curtis, Gautam Goel, et al.. (2015). Pyruvate Kinase M2 Regulates Hif-1α Activity and IL-1β Induction and Is a Critical Determinant of the Warburg Effect in LPS-Activated Macrophages. Cell Metabolism. 21(1). 65–80. 1029 indexed citations breakdown →
13.
Wang, Yinghua, William J. Israelsen, Dongjun Lee, et al.. (2014). Cell-State-Specific Metabolic Dependency in Hematopoiesis and Leukemogenesis. Cell. 158(6). 1309–1323. 258 indexed citations
14.
Wang, Yinghua, William J. Israelsen, Dongjun Lee, et al.. (2013). Differential Dependence On Aerobic Glycolysis In Normal and Malignant Hematopoietic Stem and Progenitor Cells To Sustain Daughter Cell Production. Blood. 122(21). 793–793. 2 indexed citations
15.
Walsh, Martin J., Kyle R. Brimacombe, Dimitrios Anastasiou, et al.. (2013). ML265: A potent PKM2 activator induces tetramerization and reduces tumor formation and size in a mouse xenograft model. 29 indexed citations
16.
Heiden, Matthew G. Vander, Sophia Y. Lunt, Talya L. Dayton, et al.. (2011). Metabolic Pathway Alterations that Support Cell Proliferation. Cold Spring Harbor Symposia on Quantitative Biology. 76(0). 325–334. 17 indexed citations
17.
Walsh, Martin J., Kyle R. Brimacombe, Henrike Veith, et al.. (2011). 2-Oxo-N-aryl-1,2,3,4-tetrahydroquinoline-6-sulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorganic & Medicinal Chemistry Letters. 21(21). 6322–6327. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026